Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
5.
An Med Interna ; 15(4): 211-3, 1998 Apr.
Artículo en Español | MEDLINE | ID: mdl-9608067

RESUMEN

The pyomyositis is still being a rare disease in our environment. A review of this illness is made as a result of a new case, which shows some peculiarities that differ it from others published previously: the patient showed a basic medullary carcynoma of thyroid with cerebral metastasis and the responsible germ was a Streptococcus pneumoniae. The immunodepressor factors which are presented at most patients who suffer a pyomyositis, the clinic picture so suggestive and the image methods we dispose nowadays, should serve to suspect its diagnostic in an earlier way, proceeding to its bacteriological confirmation before illness evolves to stages as advanced as in the shown case.


Asunto(s)
Miositis/diagnóstico , Infecciones Neumocócicas/diagnóstico , Neoplasias Encefálicas/complicaciones , Neoplasias Encefálicas/secundario , Femenino , Humanos , Persona de Mediana Edad , Miositis/complicaciones , Miositis/microbiología , Infecciones Neumocócicas/complicaciones , Neoplasias de la Tiroides/complicaciones , Neoplasias de la Tiroides/patología
6.
Enferm Infecc Microbiol Clin ; 16(10): 465-70, 1998 Dec.
Artículo en Español | MEDLINE | ID: mdl-9918993

RESUMEN

BACKGROUND: To assess the efficiency and safety of intravenous antibiotic therapy (IAT) when performed through the traditional simple infusion system by gravity in the home setting. PATIENTS AND METHODS: The clinical records of patients undergoing intravenous antibiotic therapy through the traditional gravitational infusion system in the home care unit over a five year period were reviewed retrospectively. RESULTS: 120 patients were treated (44 F/76 M), with a mean age of 48 years (44-52). 67% of the total had chronic diseases. Infections were most commonly found in bones and joints (38%), followed by the skin and soft tissues. A wide variety of antibiotics was used, 61% as monotherapy. 76% of them were given intermittently. 161 intravenous catheters were used, 53% of which were central catheters with peripheral insertion, 27% inserted centrally and 20% peripheral catheters. The overall incidence of phlebitis was 18% without associated bacteremia. 91% of our patients evolved well, 6% had to become in-patients, none of them due to problems with the infusion system or by their own petition. The intravenous treatment lasted a mean of 17 days at home and 25 days at both home and hospital, which represents a decrease of 2,040 hospital stays. CONCLUSIONS: The traditional gravitational system of infusion is an effective and safe method for intravenous antibiotic administration at home. For these therapies to be successful, suitable patients must be selected and continuous attention is required. This treatment at home satisfies the patient and permits hospital stays to be reduced, thus improving the use of hospital resources.


Asunto(s)
Antibacterianos/administración & dosificación , Servicios de Atención de Salud a Domicilio , Adulto , Enfermedad Crónica , Femenino , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , España
9.
An Med Interna ; 12(10): 495-7, 1995 Oct.
Artículo en Español | MEDLINE | ID: mdl-8519940

RESUMEN

Pulmonary eosinophilias are characterized by the appearance of lung infiltrates by eosinophils and the presence, commonly, of peripheral blood eosinophilia. Among idiopathic pulmonary eosinophilias, with no evidence of any cause or underlying disease, chronic eosinophilic pneumonia is the most characteristic. Recently, there has been described a few cases of eosinophilic pneumonia with many similarities to chronic eosinophilic pneumonia but with a shorter clinical course, a very good response to corticoid therapy, and without tendency to relapse. This process has been named acute eosinophilic pneumonia. We present a case of this entity and review the literature, emphasizing on the potential severity of this disease, which often conduce to progressive respiratory failure, and its excellent prognosis after appropriate treatment.


Asunto(s)
Eosinofilia Pulmonar , Enfermedad Aguda , Biopsia , Femenino , Humanos , Pulmón/patología , Persona de Mediana Edad , Eosinofilia Pulmonar/complicaciones , Eosinofilia Pulmonar/diagnóstico por imagen , Eosinofilia Pulmonar/patología , Radiografía
12.
Med Clin (Barc) ; 99(10): 368-70, 1992 Oct 03.
Artículo en Español | MEDLINE | ID: mdl-1460878

RESUMEN

BACKGROUND: Bacteremias by gram negative bacilli (BGNB) are serious diseases which normally require hospital admission. In accordance with the pharmacokinetic characteristics of ceftriaxone, the possibility of treating such processes with home care (HC) and the existence of advantages for both the patient and the hospital were evaluated. METHODS: Twenty patients were prospectively studied. Upon obtaining clinical stability in the hospital the possibility of following home care (HC) treatment was evaluated. Ceftriaxone was administrated at intramuscular doses of 1g/24 h. The clinical and bacteriologic response, patient satisfaction and treatment time were estimated. RESULTS: The origin of the bacteremia was varied as was the type of gram negative bacilli responsible. All the patients evolved favorably with no relevant secondary effects. The mean length of treatment was 12.75 days per patient. The antibiotic was mainly administered at home (83%), permitting a mean reduction of 10.5 hospital stays per patient. The social and psychologic advantages for the patients were evident. CONCLUSIONS: This study confirms the possibility of treating stable phase gram negative bacilli bacteremias at home efficiently with the supervision of home care teams leading to a substantial reduction in hospital expenses and patient satisfaction.


Asunto(s)
Bacteriemia/tratamiento farmacológico , Ceftriaxona/uso terapéutico , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Servicios de Atención de Salud a Domicilio , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Ceftriaxona/administración & dosificación , Humanos , Inyecciones Intramusculares , Persona de Mediana Edad , Estudios Prospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA